These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


922 related items for PubMed ID: 21377409

  • 1. Clonal origin of Epstein-Barr virus (EBV)-infected T/NK-cell subpopulations in EBV-positive T/NK-cell lymphoproliferative disorders of childhood.
    Ohga S, Ishimura M, Yoshimoto G, Miyamoto T, Takada H, Tanaka T, Ohshima K, Ogawa Y, Imadome K, Abe Y, Akashi K, Hara T.
    J Clin Virol; 2011 May; 51(1):31-7. PubMed ID: 21377409
    [Abstract] [Full Text] [Related]

  • 2. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K, Ohshima K, Karube K, Suzumiya J, Ohga S, Ishihara S, Tamura K, Kikuchi M.
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [Abstract] [Full Text] [Related]

  • 3. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD.
    Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK, CAEBV Study Group.
    Pathol Int; 2008 Apr; 58(4):209-17. PubMed ID: 18324913
    [Abstract] [Full Text] [Related]

  • 4. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T, Kishimoto T, Inoue M, Honda M, Yamashita N, Wakiguchi H, Yagita M, Hosoi G, Sako M, Yasui M, Yagi K, Kawa K.
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [Abstract] [Full Text] [Related]

  • 5. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection.
    Endo R, Yoshioka M, Ebihara T, Ishiguro N, Kikuta H, Kobayashi K.
    Med Hypotheses; 2004 Jan; 63(4):582-7. PubMed ID: 15325000
    [Abstract] [Full Text] [Related]

  • 6. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY, Baek JO, Lee JR, Park SH, Jeon IS, Roh JY.
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [Abstract] [Full Text] [Related]

  • 7. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E, Ohshima K, Kimura H, Hara K, Suzuki R, Kawa K, Eimoto T, Nakamura S, NK-cell Tumor Study Group.
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E, Ohga S, Kuroda H, Yoshiba F, Nishimura M, Nagasawa M, Inoue M, Kawa K.
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [Abstract] [Full Text] [Related]

  • 9. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
    Kimura H.
    Rev Med Virol; 2006 Sep; 16(4):251-61. PubMed ID: 16791843
    [Abstract] [Full Text] [Related]

  • 10. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
    Isobe Y, Aritaka N, Setoguchi Y, Ito Y, Kimura H, Hamano Y, Sugimoto K, Komatsu N.
    J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
    [Abstract] [Full Text] [Related]

  • 11. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC, Chang ST, Hsieh YC, Huang WT, Hsu JD, Tseng CE, Wang MC, Hwang WS, Wang J, Chuang SS.
    Int J Clin Exp Pathol; 2014 Mar; 7(5):2430-7. PubMed ID: 24966953
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W, Suwiwat S, Pradutkanchana J, Saechan V, Ishida T, Takao S, Mori A.
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [Abstract] [Full Text] [Related]

  • 13. NK-cell repertoire is feasible for diagnosing Epstein-Barr virus-infected NK-cell lymphoproliferative disease and evaluating the treatment effect.
    Sawada A, Sato E, Koyama M, Higuchi B, Kusuki S, Kim JY, Takeshita Y, Sakata A, Sakata N, Okamura T, Yasui M, Inoue M, Kawa K.
    Am J Hematol; 2006 Aug; 81(8):576-81. PubMed ID: 16823820
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH, Choe JY, Kim H, Lee JO, Kang HJ, Shin HY, Lee DS, Heo DS, Kim CW, Cho KH, Kim TM, Jeon YK.
    Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
    [Abstract] [Full Text] [Related]

  • 15. Fatal non-transplant-related epstein-barr virus-associated atypical lymphoid proliferations in infants and children: a clinicopathologic study.
    Salama ME, Parham DM, Perkins SL, Bahler DW, Ellison DA.
    Pediatr Dev Pathol; 2008 Jan; 11(6):443-9. PubMed ID: 18473605
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
    Kato S, Miyata T, Takata K, Shimada S, Ito Y, Tomita A, Elsayed AA, Takahashi E, Asano N, Kinoshita T, Kimura H, Nakamura S.
    Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus (EBV)-associated post-transplantation lymphoproliferative disorder simultaneously affecting both B and T cells after allogeneic bone marrow transplantation.
    Chuhjo T, Yachie A, Kanegane H, Kimura H, Shiobara S, Nakao S.
    Am J Hematol; 2003 Apr; 72(4):255-8. PubMed ID: 12666136
    [Abstract] [Full Text] [Related]

  • 18. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
    Ohga S, Nomura A, Takada H, Tanaka T, Furuno K, Takahata Y, Kinukawa N, Fukushima N, Imai S, Hara T.
    J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
    [Abstract] [Full Text] [Related]

  • 19. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
    Yin CC, Medeiros LJ, Abruzzo LV, Jones D, Farhood AI, Thomazy VA.
    Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046
    [Abstract] [Full Text] [Related]

  • 20. [Clinical features and laboratory findings of adult Epstein-Barr virus associated T/NK lymphoproliferative disease].
    Zhang Q, Zhang HY, Zhang WL, Zhong FL, Feng J, Meng QX, Yin WH, Nie LP.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):953-7. PubMed ID: 23998592
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 47.